Cargando…

肺腺癌吉非替尼获得性耐药相关microRNAs的筛选鉴定

BACKGROUND AND OBJECTIVE: Acquired gefitinib-resistance was closely related to inefficiency of EGFRTKI treatment in lung adenocarcinoma. However, it was not clear that how microRNAs influenced the acquired gefitinibresistance in lung adenocarcinoma. The aim of this study is to screen and identify th...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999882/
https://www.ncbi.nlm.nih.gov/pubmed/21645449
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.18